CONTACT US
INTERNATIONAL
INVESTORS
CAREERS
FIND A PROVIDER

Blog

When to Suggest SRT Therapy Over Mohs Surgery

For decades, Mohs surgery has been considered the “gold standard” for the treatment of basal cell carcinomas and squamous cell carcinomas, even for cases where cosmetically important features of the face like the eyes, nose, lips, ears, and scalp are the area being treated. As the incidence of basal cell carcinoma and squamous cell carcinoma […]

How to Perform a Skin Cancer Self-Exam

According to the Skin Cancer Foundation, adults should thoroughly examine their skin on a monthly basis for signs of skin cancer, as well as visit a dermatologist for an annual professional skin exam. If you’ve never conducted a skin cancer self-exam before, now is the best time to start. Here are some tips to help […]

Sensus Healthcare to Host Fourth Quarter and Fiscal Year 2017 Financial Results and Business Update Conference Call on February 1, 2018

BOCA RATON, Fla., Jan. 25, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, February 1, 2018 at 4:30 p.m. ET to discuss the financial results for […]

Offer Skin Cancer Treatment Without Surgery

Treating Non-Melanoma Skin Cancers When a person discovers they have non-melanoma skin cancer such as basal cell carcinoma or squamous cell carcinoma, the first question they have is, “How can I treat this?” The current most popular method of treatment for non-melanoma skin cancers is Mohs surgery. It’s praised for its effectiveness in successfully treating […]

Frequently Asked Questions About Keloid Scars

What’s the difference between hypertrophic scars and keloid scars? Hypertrophic scars are thick, raised scars that develop in the area where the skin is injured. Scars are normal during the human body’s healing process, but a hypertrophic scar is the result of an abnormal response to skin injury. The body produces too much collagen, so […]

Physician Spotlight – January 2018

Michael H. Gold, M.D., FAAD Founder and Medical Director of Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser & Rejuvenation Center, and Tennessee Clinical Research Center: Clinical Assistant Professor, Vanderbilt University School of Nursing, Nashville, TN. As a dermatologist, we are constantly faced with skin cancers and with keloids in our practices. We […]

Should I Get the SRT-100 for My Practice?

Superficial radiation therapy was first used to treat non-melanoma skin cancers, such as basal cell and squamous cell carcinomas, back in the 1970s. For the last few decades, the treatment method fell out of use due to a decline in available machinery. Now, the treatment is making a resurgence as our machine becomes more widespread. […]

The Best Keloid Scar Treatment Options

If you have keloid scars, chances are you’ve struggled with them for a while. These scars are notorious for their ability to resist attempts to treat or remove them, and often regrow a few years later. You have most likely asked yourself how to remove keloid scars a number of times. Here are a few […]

Simple Daily Habits for Success – Inc.com

Looking to set yourself apart from the crowd in business or in life? Find out what Sensus Healthcare Co-Founder, Chairman and CEO, Joseph Sardano, has to say about it in Christina DesMarais’s article 24 Simple Daily Habits These High Achievers Swear by for Their Success on Inc.com. It’s that simple! “When you manage a results oriented […]

Sensus Healthcare Reports Third Quarter Financial Results Featuring Revenue up 44%

Marks eighth consecutive quarter of double-digit year-over-year revenue growth Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 2, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results for the […]

Sensus Healthcare Launches SRT-100 in China for Keloid Prevention and Treatment at Major Dermatology Conference, Extends Distribution Agreement with Chindex Medical

BOCA RATON, Fla., Nov. 1, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces it has launched the SRT-100™ in China for the treatment and prevention of keloids with Chindex Medical Limited. Sensus also announces the […]

Sensus Healthcare Announces Clearance to Market the SRT-100™ in Mexico

BOCA RATON, Fla., Oct. 31, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the SRT-100™ is now cleared for sale in Mexico. The system is approved for the treatment of non-melanoma skin cancer and […]

What is Superficial Radio Therapy? (SRT)

What is Superficial Radio Therapy? Superficial Radio Therapy is the latest non-invasive, non-melanoma skin cancer treatment option. Superficial Radio Therapy is administered with the use of the SRT-100™, our state-of-the-art system inspired by the tried-and-true Superficial Radio Therapy systems that were once the proven gold standard among dermatologists and radiation oncologists. The difference? Our machine […]

Sensus Healthcare to Host Third Quarter 2017 Financial Results and Business Update Conference Call on November 2, 2017

BOCA RATON, Fla., Oct. 25, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radio Therapy (SRT), announces that management will hold a conference call on Thursday, November 2, 2017 at 4:30 p.m. Eastern time to discuss the financial results for […]